BCTX
Briacell Therapeutics
BCTX
BCTX
19 hedge funds and large institutions have $4.77M invested in Briacell Therapeutics in 2021 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
19
Holders Change
-3
Holders Change %
-13.64%
% of All Funds
0.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
2
Reduced
4
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
Voloridge Investment Management
Jupiter,
Florida
|
+$1.27M |
2 |
Two Sigma Investments
New York
|
+$503K |
3 |
Geode Capital Management
Boston,
Massachusetts
|
+$326K |
4 |
Jane Street
New York
|
+$285K |
5 |
VF
Virtu Financial
New York
|
+$267K |
Top Sellers
1 |
ACM
Altium Capital Management
New York
|
-$4.27M |
2 |
AC
Armistice Capital
New York
|
-$3.04M |
3 |
KC
Kepos Capital
New York
|
-$2.67M |
4 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$2.13M |
5 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$1.71M |